Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational/in silico methods in drug target and lead prediction
Francis E. Agamah, Gaston K. Mazandu, Radia Hassan, et al.
Briefings in Bioinformatics (2019) Vol. 21, Iss. 5, pp. 1663-1675
Open Access | Times Cited: 205

Showing 51-75 of 205 citing articles:

Drug repurposing for cancer
Juni Banerjee, Anand Krishna Tiwari, Shuvomoy Banerjee
Progress in molecular biology and translational science (2024), pp. 123-150
Closed Access | Times Cited: 2
Drug repurposing for neurodegenerative diseases
Halak Shukla, D. James B. St. John, Shuvomoy Banerjee, et al.
Progress in molecular biology and translational science (2024), pp. 249-319
Closed Access | Times Cited: 2
Phylogenetic Tracing of Evolutionarily Conserved Zonula Occludens Toxin Reveals a “High Value” Vaccine Candidate Specific for Treating Multi-Strain Pseudomonas aeruginosa Infections
Payam Benyamini
Toxins (2024) Vol. 16, Iss. 6, pp. 271-271
Open Access | Times Cited: 2
Exploration of Type III effector Xanthomonas outer protein Q (XopQ) inhibitor from Picrasma quassioides as an antibacterial agent using chemoinformatics analysis
Prasanna D. Revanasiddappa, Hittanahallikoppal Gajendramurthy Gowtham, G. S. Chikkanna, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0302105-e0302105
Open Access | Times Cited: 2
Targeting Oral Cancer: In Silico Docking Studies of Phytochemicals on Oncogenic Molecular Markers
G. Sathya Priyadarshini, Gheena Sukumaran, E. Dilipan, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 6, pp. 2069-2075
Open Access | Times Cited: 2
Artificial Intelligence in Drug Discovery and Development
Kit‐Kay Mak, Yi-Hang Wong, Mallikarjuna Rao Pichika
Springer eBooks (2024), pp. 1461-1498
Closed Access | Times Cited: 2
“Tomorrow Never Dies”: Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies
Partha Laskar, Murali M. Yallapu, Subhash C. Chauhan
Diseases (2020) Vol. 8, Iss. 3, pp. 30-30
Open Access | Times Cited: 24
Scope of 3D Shape-Based Approaches in Predicting the Macromolecular Targets of Structurally Complex Small Molecules Including Natural Products and Macrocyclic Ligands
Ya Chen, Neann Mathai, Johannes Kirchmair
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 6, pp. 2858-2875
Open Access | Times Cited: 23
A single-molecule with multiple investigations: Synthesis, characterization, computational methods, inhibitory activity against Alzheimer's disease, toxicity, and ADME studies
Songül Şahin
Computers in Biology and Medicine (2022) Vol. 146, pp. 105514-105514
Closed Access | Times Cited: 14
Artificial Intelligence and Machine Learning for Lead-to-Candidate Decision-Making and Beyond
Douglas McNair
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 77-97
Open Access | Times Cited: 14
Identification of a Novel Theranostic Signature of Metabolic and Immune-Inflammatory Dysregulation in Myocardial Infarction, and the Potential Therapeutic Properties of Ovatodiolide, a Diterpenoid Derivative
Alexander T.H. Wu, Bashir Lawal, Yew‐Min Tzeng, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1281-1281
Open Access | Times Cited: 13
Applications of machine learning in microbial natural product drug discovery
Autumn Arnold, Jeremie Alexander, Gary Liu, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 11, pp. 1259-1272
Closed Access | Times Cited: 7
LigTMap: ligand and structure-based target identification and activity prediction for small molecular compounds
Faraz Shaikh, Hio Kuan Tai, Nirali Desai, et al.
Journal of Cheminformatics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 19
(E)-N-(3-chlorophenyl)-1-(5-nitro-2-(piperidin-1-yl)phenyl)methanimine: X-Ray, DFT, ADMET, Boiled-Egg Model, Druggability, Bioavailabilty, and Human Cyclophilin D (CypD) Inhibitory Activity
Songül Şahin, Necmi Dege
Journal of Molecular Structure (2021) Vol. 1250, pp. 131744-131744
Closed Access | Times Cited: 18
In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K
Vinothini Boopathi, Jinnatun Nahar, Mohanapriya Murugesan, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19341-e19341
Open Access | Times Cited: 6
In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein
Yu-Chao Lin, Wen‐Yih Chen, En‐Te Hwu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5810-5810
Open Access | Times Cited: 10
Computational Prediction of the Phenotypic Effect of Flavonoids on Adiponectin Biosynthesis
Seungchan An, Seok Young Hwang, Junpyo Gong, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 3, pp. 856-869
Closed Access | Times Cited: 5
Target identification by structure-based computational approaches: Recent advances and perspectives
Simona De Vita, Maria Giovanna Chini, Giuseppe Bifulco, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 83, pp. 129171-129171
Open Access | Times Cited: 5
Waste to Medicine: Evidence from Computational Studies on the Modulatory Role of Corn Silk on the Therapeutic Targets Implicated in Type 2 Diabetes Mellitus
Ayesha Akoonjee, Adedayo Ayodeji Lanrewaju, Fatai Oladunni Balogun, et al.
Biology (2023) Vol. 12, Iss. 12, pp. 1509-1509
Open Access | Times Cited: 5
Chemical pharmacognosy in natural drug discovery-bridging folk wisdom and modern medicine
Salman Ahmed, Shahnila Jamil
Journal of Pharmacognosy and Phytochemistry (2024) Vol. 13, Iss. 1, pp. 391-398
Open Access | Times Cited: 1
Multilevel Attention Network with Semi-supervised Domain Adaptation for Drug-Target Prediction
Zhousan Xie, Shikui Tu, Lei Xu
Proceedings of the AAAI Conference on Artificial Intelligence (2024) Vol. 38, Iss. 1, pp. 329-337
Open Access | Times Cited: 1
Corydalis ternata Nakai Alleviates Cognitive Decline in Alzheimer's Disease by Reducing β-Amyloid and Neuroinflammation
Bomi Lee, Myeong‐Sang Yu, Jae Gwang Song, et al.
Rejuvenation Research (2024) Vol. 27, Iss. 3, pp. 87-101
Closed Access | Times Cited: 1
Computational Approaches for the Inhibition of ESKAPE Pathogens
Subhaswaraj Pattnaik, Monika Mishra, Pradeep Kumar Naik
(2024), pp. 503-544
Closed Access | Times Cited: 1
Comprehensive approaches to preclinical evaluation of monoclonal antibodies and their next-generation derivatives
Santanu Singh, Kajal Kachhawaha, Sumit K. Singh
Biochemical Pharmacology (2024) Vol. 225, pp. 116303-116303
Closed Access | Times Cited: 1
ERNEST COST action overview on the (patho)physiology of GPCRs and orphan GPCRs in the nervous system
Necla Birgül İyison, Clauda Abboud, Dayana Abboud, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1

Scroll to top